Scott Carroll

All filings by Scott Carroll on record concern Cannara Biotech Inc. The record holds 4 filings, for trades running from 1 April 2022 to 30 May 2023.

On the market, this insider has only ever bought: 3 purchases, €2,011 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2023 alone, the filings show 3 purchases and no sales.

A typical purchase (the median) is worth €671. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The newest entry dates from 4 June 2023: a transaction, in Cannara Biotech Inc. The latest purchase dates back some time: it was published 1,241 days ago, on 4 June 2023. Between a trade and the moment it shows up on SEDI, the median delay is 10 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.